Related Experiment Video
Updated: Jun 5, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial
Emily A Morell1, Daniel M Balkin
1Harvard Medical School/Castle Society, Boston, Massachusetts 02115, USA. emily_morell@hms.harvard.edu
Abstract:
Staphylococcus aureus (S. aureus) has entered the spotlight as a globally pervasive drug-resistant pathogen. While historically associated exclusively with hospital-acquired infections in immunocompromised hosts, the methicillin-resistant form of S. aureus has been spreading throughout communities since the 1990s. Indeed, it has now become a common household term: MRSA. S. aureus has developed numerous mechanisms of virulence and strategies to evade the human immune system, including a host of surface proteins, secreted enzymes, and toxins. In hospital intensive care units, the proportion of MRSA-related S. aureus infections has increased strikingly from just 2 percent in 1974 to 64 percent in 2004. Its presence in the community has been rising similarly, posing a significant public health burden. The growing incidence of MRSA unfortunately has been met with dwindling efforts to develop new, more effective antibiotics. The continued emergence of resistant strains of bacteria such as MRSA demands an urgent revival of the search for new antibiotics.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) is a growing global threat, causing both hospital and community infections. Urgent development of new antibiotics is critical due to increasing resistance.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Staphylococcus aureus (S. aureus) is a significant pathogen, with its drug-resistant form, methicillin-resistant S. aureus (MRSA), becoming globally pervasive.
- MRSA infections have transitioned from primarily hospital-acquired to widespread community-acquired, posing a substantial public health burden.
- S. aureus possesses diverse virulence factors and immune evasion strategies, including surface proteins, secreted enzymes, and toxins.
Purpose of the Study:
- To highlight the increasing prevalence and public health impact of MRSA infections.
- To underscore the critical need for renewed efforts in developing novel antibiotics against resistant bacterial strains.
Main Methods:
- Analysis of historical and current infection data for S. aureus and MRSA.
- Review of S. aureus virulence mechanisms and immune evasion strategies.
Main Results:
- MRSA proportion of S. aureus infections in ICUs rose from 2% in 1974 to 64% in 2004.
- Community prevalence of MRSA has also significantly increased.
- Development of new antibiotics against resistant bacteria has lagged behind the emergence of resistance.
Conclusions:
- The escalating incidence of MRSA necessitates an urgent revival in the search for new and effective antibiotics.
- Addressing the growing threat of antibiotic resistance requires a concerted global effort in antimicrobial research and development.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Staphylococcal Skin Infections
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antibiotic Selection